Przyczyny i skutki zakazu stosowania 5-nitroimidazoli u zwierząt, których tkanki lub produkty przeznaczone są do spożycia przez ludzi

• Autorzy: Mitrowska K.

Warianty tytułu

EN

Reasons and consequences of the ban on the use of 5-nitroimidazoles in food producing animals

• Języki publikacji: PL

Abstrakty

EN

Nitroimidazoles have been used for the treatment of anaerobic bacterial and parasitic infections in animals. However, they are believed to possess genotoxic and carcinogenic properties, which is why their use in food producing animals has been banned in many countries. At present, nitroimidazoles are approved in the European Union only for use in companion animals and human medicine, although the reason for the ban of their use in food producing animals was just care about the health of people. As a consequence of this ban each European Union country and countries wishing to export animal products to the European Union are required to implement a residue monitoring plan for nitroimidazole residues in food of animal origin which helps to ensure the safety and reduce the possible health risks to consumers. In this article the pharmacological and toxicological aspects of the most commonly used 5-nitroimidazoles in veterinary medicine are summarized.

Słowa kluczowe

PL

chemioterapeutyki; nitroimidazole; 5-nitroimidazole; farmakokinetyka; produkty zwierzece; tkanki zwierzece; pozostalosci lekow weterynaryjnych; toksykologia; dzialanie kancerogenne; dzialanie genotoksyczne; zakaz stosowania

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 12
• Opis fizyczny: s.736-742,rys.,tab.,bibliogr.

Twórcy

autor

Mitrowska K.

• Zakład Farmakologii i Toksykologii, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy w Puławach, Al.Partyzantów 57, 24-100 Puławy

Bibliografia

• 1. Aerts R. M. L., Egberink I. M., Kan C. A., Keukens H. J., Beek W. M. J.: Liquid chromatographic multicomponent method for determination of residues of ipronidazole, ronidazole, and dimetridazole and some relevant metabolites in eggs, plasma, and feces and its use in depletion studies in laying hens. J. AOAC Int. 1991, 74, 46-55.
• 2. Beard C. M., Noller K. L., O’Fallon W. M., Kurland L. T., Dahlin D. C.: Cancer after exposure to metronidazole. Mayo Clin. Proc. 1988, 63, 147-153.
• 3. Beard C. M., Noller K. L., O’Fallon W. M., Kurland L. T., Dockerty M. B.: Lack of evidence for cancer due to use of metronidazole. N. Engl. J. Med. 1979, 301, 519-522.
• 4. Bhavsar S. K., Malik J. K.: Pharmacokinetics of metronidazole in calves. Br. Vet. J. 1994, 150, 389-393.
• 5. Commission Regulation (EC) No 613/98. Off J Eur Commun. 19.03.1998, L 82, 14.
• 6. Commission Regulation (EC) No 1798/95. Off J Eur Commun. 26.07.1995, L 174, 20.
• 7. Commission Regulation (EC) No 3426/93. Off J Eur Commun. 15.12.1993, L 312, 15.
• 8. Commission Staff Working Documents on the Implementation of National Residue Monitoring Plans in the Member States in 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012 (Council Directive 96/23/EC).
• 9. CRL Guidance Paper, CRLs view on state of the art analytical methods for national residue control plans. 2007, December 2007.
• 10. Cybulski W., Larsson P., Tjalve H., Kowalska-Pylka H., Sylla M., Semeniuk S.: Disposition of metronidazole in hens (Gallus gallus) and quails (Coturnix coturnix japonica): pharmacokinetics and whole-body autoradiography. J. Vet. Pharmacol. Ther. 1996, 19, 352-358.
• 11. Decyzja Komisji 2002/657/WE. Dz.U. L 221 z 17.8.2002, s. 8.
• 12. Dyrektywa Komisji 98/19/WE. Dz.U. L 96 z 28.3.1998, s. 39.
• 13. Dyrektywa Rady 96/23/WE. Dz.U. L 125 z 23.5.1996, s. 10.
• 14. Edwards D. I.: Nitroimidazole drugs – action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 1993, 31, 9-20.
• 15. The European Agency for the Evaluation of Medical Products. Committee for Veterinary Medicinal Products. Summary Report. Dimetridazole. 1996.
• 16. The European Agency for the Evaluation of Medical Products. Committee for Veterinary Medicinal Products. Summary Report. Metronidazole. In 1997.
• 17. Food and Drug Administration. Federal Register 1980;44:37434-67.
• 18. Friis C.: Disposition kinetics of metronidazole in the cow. Acta Vet. Scand. 1991, 87 (Suppl.), 155-157.
• 19. Giguère S., Prescott J. F., Dowling P. M.: Antimicrobial therapy in veterinary medicine, fifth edition. John Wiley&Sons, Inc. Ames, Iowa 2013.
• 20. International Agency for Research on Cancer (IARC): Monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity. Suppl. 7. 1987, 250.
• 21. Joint FAO/WHO Expert Committee on Food Additives (JECFA). Residues of some veterinary drugs in animals and foods. FAO Food and Nutrition Paper 41/2. Monographs prepared by the Thirty-Fourth Meeting of the Joint FAO/WHO Expert Committee on Food Additives, Geneva, 30 January – 8 February 1989.
• 22. Joint FAO/WHO Expert Committee on Food Additives (JECFA), Toxicological evaluation of certain veterinary drug residues in food. WHO Food Additives Series, No. 25. 1990.
• 23. Joint FAO/WHO Food Standards Programme. Codex Committee on residues of veterinary drugs in foods: Discussion paper on veterinary drugs in honey production. 2010, Agenda Item 10 CX/RVDF 10/19/10.
• 24. Mitrowska K., Antczak M., Posyniak A.: A confirmatory method for the determination of nitroimidazoles in milk by liquid chromatography – tandem mass spectrometry. Bulletin of the Veterinary Institute in Pulawy 2014, 58, 581-587.
• 25. Mitrowska K., Posyniak A., Zmudzki J.: Multiresidue method for the determination of nitroimidazoles and their hydroxy-metabolites in poultry muscle, plasma and egg by isotope dilution liquid chromatography mass spectrometry. Talanta. 2010, 81, 1273-1280.
• 26. Mitrowska K., Posyniak A., Zmudzki J.: Selective determination of fourteen nitroimidazoles in honey by high-performance liquid chromatography–tandem mass spectrometry. Anal. Lett. 2014, 47, 1634-1649.
• 27. Passmore C. M., McElnay J. C., Rainey E. A., D’Arcy P. F.: Metronidazole excretion in human milk and its effect on the suckling neonate. Br. J. Clin. Pharmacol. 1988, 26, 45-51.
• 28. Polzer J., Stachel C., Gowik P.: Treatment of turkeys with nitroimidazoles impact of the selection of target analytes and matrices on an effective residue control. Anal. Chim. Acta. 2004, 521, 189-200.
• 29. Posyniak A., Semeniuk S., Zmudzki J., Niedzielska J., Biernacki B.: Residues of dimetridazole in eggs after treatment of laying hens. Vet. Res. Commun. 1996, 20, 167-174.
• 30. Posyniak A., Semeniuk S., Zmudzki J., Niedzielska J., Biernacki B.: Tissue concentration of dimetridazole in laying hens. Food Addit. Contam. 1996, 13, 871-877.
• 31. Radko L., Minta M.: Cytotoxicity of some nitroimidazole derivatives – comparative studies on human and rat hepatoma cell lines. Bulletin of the Veterinary Institute in Pulawy. 2012, 56, 579-584.
• 32. Rico A. G., Burgat-Sacaze V.: Toxicological significance of covalently-bound residues. Food Addit. Contam. 1984, 1, 157-161.
• 33. Roe F. J.: Safety of nitroimidazoles. Scand. J. Infect. Dis. Suppl. 1985, 46, 72-81.
• 34. Roe F. J.: Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 1983, 93, 158-164.
• 35. Roliński Z.: Farmakologia i farmakoterapia weterynaryjna. PWRiL, Warszawa 2008.
• 36. Rosado T. W., Specht A., Marks S. L.: Neurotoxicosis in 4 cats receiving ronidazole. J. Vet. Intern. Med. 2007, 21, 328-331.
• 37. Rose M. D., Bygrave J., Sharman M.: Effect of cooking on veterinary drug residues in food. Part 9. Nitroimidazoles. Analyst. 1999, 124, 289-294.
• 38. Rozporządzenie Komisji (UE) NR 37/2010 z dnia 22 grudnia 2009 r. w sprawie substancji farmakologicznie czynnych i ich klasyfikacji w odniesieniu do maksymalnych limitów pozostałości w środkach spożywczych pochodzenia zwierzęcego. Dz.U. L 15 z 20.1.2010, s. 1.
• 39. Rozporządzenie Komisji (WE) NR 2205/2001. Dz.U. L 297 z 15.11.2001, s. 3.
• 40. Rozporządzenie Komisji (WE) NR 45/1999. Dz.U. L 6 z 12.1.1999, s. 3.
• 41. Rozporządzenie Rady (EWG) NR 2377/90. Dz.U. L 224 z 18.8.1990, s. 1.
• 42. Semeniuk S., Posyniak A., Niedzielska J., Zmudzki J.: Determination of nitroimidazole residues in poultry tissues, serum and eggs by high-performance liquid-chromatography. Biomed. Chromatogr. 1995, 9, 238-242.
• 43. Sorensen L. K., Hansen H.: Determination of metronidazole and hydroxymetronidazole in trout by a high-performance liquid chromatographic method. Food Addit. Contam. 2000, 17, 197-203.
• 44. Sved S., Foster B.: Nitroimidazoles: proposed studies on the toxicity of bound residues. Drug Metab. Rev. 1990, 22, 849-861.
• 45. Thapa P. B., Whitlock J. A., Brockman Worrell K. G., Gideon P., Mitchel E. F., Jr., Roberson P., Pais R., Ray W. A.: Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years. Cancer 1998, 83, 1461-1468.
• 46. Treves-Brown K. M.: Applied fish pharmacology. Kluwer Academic Publishers. Dordrecht 2000.
• 47. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Metronidazole, Report on Carcinogens, 12th edn, 2011, s. 269-270.
• 48. Vynckier L. J., Debackere M.: Plasma ronidazole concentrations in sheep after intravenous, oral, intraruminal and intraabomasal administration. J. Vet. Pharmacol. Ther. 1993, 16, 70-78.
• 49. Wislocki P. G., Lu A. Y. H.: Formation and Biological Evaluation of Ronidazole Bound Residues. Drug Metab. Rev. 1990, 22, 649-661.
• 50. Żmudzki J.: Kontrola pozostałości chemicznych w tkankach zwierząt i żywności – ważny element w ochronie zdrowia publicznego. Post. Nauk Rol. 2008, 2, 49-59.